| Symbol | FEMY |
|---|---|
| Name | FEMASYS INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 3950 JOHNS CREEK COURT, SUWANEE, GA 30024 |
| Telephone | 770-500-3910 |
| Fax | — |
| — | |
| Website | https://www.femasys.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001339005 |
| Description | Femasys Inc is a biomedical company focused on transforming womens healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The companys mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Additional info from NASDAQ: |
New Form SCHEDULE 13D - FEMASYS INC <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001104659-26-097888 <b>Size:</b> 30 KB
Read more- Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
Read moreFemasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
Read moreNew Form SCHEDULE 13G - FEMASYS INC <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001622627-26-000023 <b>Size:</b> 12 KB
Read more- Femasys Strengthens and Extends Global Patent Protection forFemBloc® with First Issued Blended Polymer Patents
Read moreFemasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
Read moreEichenbaum Kenneth D. 🟢 acquired 880 shares (1 derivative) of FEMASYS INC (FEMY) at $3.67 Transaction Date: Jun 24, 2026 | Filing ID: 032349
Read moreUzialko Edward R 🟢 acquired 8.8K shares (1 derivative) of FEMASYS INC (FEMY) at $3.67 Transaction Date: Jun 24, 2026 | Filing ID: 032347
Read moreMilnes Alistair 🟢 acquired 880 shares (1 derivative) of FEMASYS INC (FEMY) at $3.67 Transaction Date: Jun 24, 2026 | Filing ID: 032345
Read moreLarsen Charles 🟢 acquired 880 shares (1 derivative) of FEMASYS INC (FEMY) at $3.67 Transaction Date: Jun 24, 2026 | Filing ID: 032339
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT05977751 | Prospective Multi-Center Trial for FemBloc Permanent Birth Control | Na | Contraception | Recruiting | 2023-10-31 | 2031-06-01 | ClinicalTrials.gov |
| NCT04968847 | FemaSeed LOCAL Artificial Insemination Trial | Na | Infertility | Completed | 2021-07-15 | 2024-04-30 | ClinicalTrials.gov |
| NCT04273594 | FemBloc® Permanent Contraception - Confirmation Feasibility Trial | Na | Contraception | Active_Not_Recruiting | 2020-02-27 | 2027-04-01 | ClinicalTrials.gov |
| NCT03433911 | FemBloc® Permanent Contraception - Early Pivotal Trial | Na | Contraception | Completed | 2018-02-02 | 2025-02-10 | ClinicalTrials.gov |
| NCT03067272 | Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception | Na | Contraception | Completed | 2017-03-15 | 2023-03-14 | ClinicalTrials.gov |
| NCT01053052 | Study of FemVue(TM) Sono Tubal Evaluation System Method Comparison to HSG | Na | Fallopian Tube Patency Tests | Withdrawn | 2010-01-01 | 2013-01-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| FemBloc | Other | Approved | Contraception | ACTIVE_NOT_RECRUITING | NCT04273594 |
| Sonography with FemVue, and HSG | Other | Approved | Fallopian Tube Patency Tests | WITHDRAWN | NCT01053052 |
| FemBloc® Permanent Contraceptive System | Other | Approved | Contraception | COMPLETED | NCT03067272 |
| FemaSeed Localized Directional Insemination | Other | Approved | Infertility | COMPLETED | NCT04968847 |
| Laparoscopic bilateral tubal sterilization | Other | Approved | Contraception | COMPLETED | NCT03433911 |
| FemBloc | Other | Approved | Contraception | COMPLETED | NCT03433911 |
| FemBloc | Other | Approved | Contraception | RECRUITING | NCT05977751 |
| FemaSeed Localized Directional Insemination | DEVICE | Approved | Infertility | COMPLETED | NCT04968847 |
| Laparoscopic bilateral tubal sterilization | PROCEDURE | Approved | Contraception | COMPLETED | NCT03433911 |
| FemBloc | DEVICE | Approved | Contraception | RECRUITING | NCT05977751 |
| FemBloc® Permanent Contraceptive System | DEVICE | Approved | Contraception | COMPLETED | NCT03067272 |
| Sonography with FemVue, and HSG | DEVICE | Approved | Fallopian Tube Patency Tests | WITHDRAWN | NCT01053052 |